Biomaterials

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology |  Biomaterials

Asia Pacific Markets for Orthopedic Biomaterials 2011 – Bone Grafting and Hyaluronic Acid Viscosupplementation Price Single License, Hard-Copy $7,995.00 Single License, PDF $8,495.00 Corporate License PDF $9,995.00 Publication Date: Jul-2011 Pages: 358 Publisher: iData Research Table of Contents The Asia-Pacific orthopedic biomaterials market is expected to approach $1.6 billion by 2017. The hyaluronic acid viscosupplementation segment is expected to constitute the majority of the Asia-Pacific orthopedic biomaterials market. The market is approaching maturity, but is expected to continue to grow as a result of the aging Asia-Pacific population. BMP growth factor therapy was the fastest growing segment in 2010, increasing almost 7% over the previous year. More...

European Markets for Orthopedic Biomaterials 2011 – Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) Price Single License, Hard-Copy $10,995.00 Single License, PDF $11,495.00 Corporate License PDF $13,995.00 Publication Date: May-2011 Pages: 318 Publisher: iData Research Table of Contents The European orthopedic biomaterials markets are expected to approach €1 billion by 2017, with hyaluronic acid viscosupplementation as the largest segment. The ACI market grew most rapidly in 2010 at a rate of nearly 12%, followed by the BGS market. Within the European orthopedic biomaterials market, companies such as Fidia, Genzyme, Rottapharm/Madaus and Smith & Nephew lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. More...

Brazil Biomaterial Market (2010 – 2015) Price Single User $4,650.00 Multi User $5,650.00 Corporate Licence $7,150.00 Enterprise Site Licence $9,000.00 Publication Date: May-2011 Format: PDF Pages: 179 Publisher: MarketsandMarkets Table of Contents The Brazil market for biomaterials is expected to reach $1.7 billion in 2015 from $550.2 million in 2008 with a CAGR of 19.5% from 2010 to 2015. In 2009, the orthopedic biomaterial market recorded revenues of $236.5 million or 37.5% of the total biomaterial products market. This is mainly because of increasing application areas and introduction of sophisticated technologies in the biomaterials market. However, the orthopedic biomaterial market is estimated to grow at a CAGR of 17.2% from 2010 to 2015. Cardiovascular biomaterial products market is the second-highest market, contributing 36% of the total biomaterial products market. More...

Global Biomaterial Market (2010 - 2015) Price Single User $4,650.00 Multi User $5,650.00 Corporate Licence $7,150.00 Enterprise Site Licence $9,000.00 Publication Date: May-2011 Format: PDF Pages: 417 Publisher: MarketsandMarkets Table of Contents The global market for biomaterials is expected to reach $64.7 billion in 2015 from $25.6 billion in 2008 with a CAGR of 15% from 2010 to 2015. In 2010, the orthopedic biomaterial market recorded revenues of $12 billion or 37.5% of the total global biomaterial market. This is mainly because of the demand generated by the increasing aging population worldwide, and introduction of sophisticated technologies in the biomaterials market. However, the orthopedic biomaterials market is estimated to grow slowly, at a CAGR of 12.7% (2010 to 2015) because the market is relatively mature compared to other product markets. Cardiovascular biomaterial is the second-highest market, and contributed 36.1% to the global biomaterial market in 2010. More...

Biomaterials that Deliver Antimicrobials: An Overview Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 31-Mar-2011 Format: PDF Pages: 8 Publisher: GlobalData More...

Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: Apr-2011 Format: PDF Pages: 81 Publisher: GBI Research More...

Opportunities in Non-Surgical Bio-Implants Price: $3,835.00 (€3,022.53) ($4,602.00 (€3,627.03) Including VAT at 20%) Publication Date: 08-Jun-2010 Please click here for more information or to purchase this report at our partner store Market opportunities for injectable bio-implants are high in an increasingly aging population that demands fast, effective, and safe treatments for age-related conditions.

Europe Orthopedic Biomaterials Market: Product Penetration to Drive Growth Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 14-Apr-2009 Format: PDF Pages: 42 Publisher: GlobalData More...

U.S. Market for Orthopedic Biomaterials 2010 Price Single License Hard-Copy $6,995.00 Single License PDF $7,495.00 Corporate License PDF $8,995.00 Publication Date: 01-Mar-2010 Format: Hard-Copy, PDF Pages: 303 Publisher: iData Research Table of Contents In 2009, the orthopedic biomaterials market was valued at almost $3.5 billion. This market is expected to grow at a CAGR of 8.9% by 2016. The total orthopedic biomaterials market has experienced growth, despite the economic downturn, which began in 2008. The market started to spike in 2009 and peaked in 2010 largely driven by rapid growth in the stem cell, hyaluronic acid and synthetic bone graft substitute market segments. More...

Global Biomaterial Market (2009-2014) Price Single User (+$4,650.00) Multi User (+$5,650.00) Corporate Licence (+$7,150.00) Enterprise Site Licence (+$9,000.00) Published: 9/9/2009 Pages: 256 Format: pdf Author: MarketsandMarkets Table of Contents The biomaterials market is defined and explained through the introduction of biotechnology and advances in the understanding of human tissue compatibility. Developing from bio-inert materials to biodegradable materials, biomaterials are widely used in medical devices, tissue replacement, and surface coating applications. The major segments in biomaterials market are ceramics, metals, polymers, and composites. Biomaterials products are classified into orthopedic, cardiovascular, gastrointestinal, wound care, urology, plastic surgery, and others. Reconstructive surgery and orthobiologics are the dominant segments in orthopedic biomaterials market. Biomaterials products had a market size of $25.5 billion in 2008, and the biomaterial device market size was $115.4 billion in the same year, and is expected to reach $252.7 billion in 2014. This massive revenue potential highlights the immense opportunity in the market. In the next five years, the biomaterials market is expected to grow at a CAGR of 15%. More...

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology |  Biomaterials